Recent Developments in Generics

Last updated July 26, 2010. For more information contact Ed Thwaite.

• Merck is moving ahead with a biosimilar using the abbreviated process.
• Momenta finally received an approval for the generic of Lovenox, after years of fighting for it.
• Mylan and Sun lost in their patent challenge to AstraZeneca's Crestor.
• Mylan is moving into the injectable generic business with its acquisition of Bioniche.
• Prasco is marketing an authorized generic of Zegerid for Santarus. This is in response to PAR's ANDA being approved.
• Teva and Sun are fighting to overturn possible massive damages after losing a patent fight and doing "at risk" launches of generics of Protonix.
• Watson is in a battle with the FTC relating to a supposed "pay-for-delay" deal with Cephalon.